ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Amentum shares rise 3.1% on $974 million NASA contract

Amentum stock gained in pre-market trading after securing a decade-long maintenance and engineering contract with NASA valued at nearly $1 billion. The S&P 500, Dow and Nasdaq were slightly lower ahead of the open.

PA
Priya Anand · Equities & Earnings Desk · 20 Aug 2026 · 14:15 · 1 min read
Share
Amentum shares rise 3.1% on $974 million NASA contract

Amentum Inc. shares climbed 3.1% in pre-market trading on Thursday after the company announced a $974 million contract with NASA's Langley Research Center in Hampton, Virginia.

The Center Maintenance, Operations, and Engineering II (CMOE II) contract spans 10 years and covers maintenance and operational support for advanced research systems, including wind tunnels, laboratories and research utilities. The agreement also includes engineering services such as design, construction, project management and pressure system recertification.

The contract award follows the company's Q3 2026 financial results, which incorporated previously disclosed contract backlog, including a roughly $500 million COSMOS flight mission operations contract and more than $1 billion in classified defense engineering and logistics awards.

Amentum highlighted a $32 billion pipeline of pending awards, with about two-thirds representing new business opportunities. The company's stock, which has a 52-week high of $38.11, was trading near the lower end of its annual range ahead of the pre-market move.

Major U.S. stock indices were modestly lower ahead of the open, with the S&P 500, Dow Jones Industrial Average and Nasdaq Composite all in negative territory.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT